|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Epidemology and Cancer Control |
Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL 60612 (B.J.M., F.D.); Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030 (J.M.B.); Central Brain Tumor Registry of the United States, Chicago, IL 60632 (B.J.M., T.S., C.K.)
2 Address correspondence and reprint requests to Carol Kruchko, Central Brain Tumor Registry of the United States, 3333 West 47th St., Chicago, IL 60632.
Abstract
The Consensus Conference on Brain Tumor Definition was facilitated by the Central Brain Tumor Registry of the United States and held on November 10, 2000, in Chicago, Illinois, to reach multidisciplinary agreement on a standard definition of brain tumors for collecting and comparing data in the U.S. The Brain Tumor Working Group, convened in 1998 to determine the status of brain tumor collection in the U.S., outlined 4 recommendations of which the first 2 guided the discussion for the Consensus Conference: (1) standardization of a definition of primary brain tumors that is based on site alone, rather than on site and behavior, and that can be used by surveillance organizations in collecting these tumors; and (2) development of a reporting scheme that can be used for comparing estimates of primary brain tumors across registries. Consensus was reached on the collection of all primary brain tumor histologies found and reported in the brain or CNS ICD-O site codes (C70.0-C72.9 and C75.1-C75.3), including those coded benign and uncertain as well as those coded malignant. In addition, a comprehensive listing of histologies occurring in the brain and CNS, based on the CBTRUS grouping scheme, was formulated to provide a template for reporting in accordance with the second recommendation of the Brain Tumor Working Group. With consensus achieved on the first 2 recommendations, the stage is set to move forward in estimating additional resources necessary for the collection of these tumors, including funding, training for cancer registrars, identifying quality control measures, and developing computerized edit checks, as outlined in the last 2 recommendations of the Brain Tumor Working Group.
References
BTWG (Brain Tumor Working Group) (1998) Surveillance of primary intracranial and central nervous system tumors: Recommendations from the Brain Tumor Working Group. National Coordinating Council for Cancer Surveillance. Cited January 3, 2002. URL: <www.naaccr.org/stats/epireports.html>.
CBTRUS (Central Brain Tumor Registry of the United States) (2000) Statistical Report: Primary Brain Tumors in the United States, 1992-1997. Chicago, Ill.: Central Brain Tumor Registry of the United States.
CDCP (Centers for Disease Control and Prevention) (2000) National Program of Cancer Registries Notice of Availability of Funds. Program Announcement No. 00027. Last reviewed December 7, 2001; cited January 3, 2002. Atlanta, Ga.: Centers for Disease Control and Prevention. URL: <www.cdc.gov/cancer/npcr/027fy00.htm>.
Davis, F.G., Bruner, J.M., and Surawicz, T.S. (1997) The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries. Neuroepidemiology 16,308 -316.[CrossRef][ISI][Medline]
Finkelstein, S.D., Papadaki, H., Kounelis, S., Przygcdski, R.M. (1997) Olfactory neuroblastoma. In: Kleihues, P., and Cavenee, W.K. (Eds.), Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press. pp.114 -116.
Fritz, A.G., and Ries, L.A.G. (Eds.) (1998)The SEER Program Code Manual. Third edition . NIH Pub. No. 98-1999. Bethesda, Md.: National Institutes of Health.
Fritz, A.G., Percy, C., Jack, A., Shanmugaratnam, K., Sobin, L., Parkin, D.M., and Whelan, S. (Eds.) (2000)International Classification of Diseases for Oncology. Third edition . Geneva: World Health Organization.
Gurney, J.G., Wall, D.A., Jukich, P.J., and Davis, F.G. (1999) The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes Control 10,101 -105.[CrossRef][ISI][Medline]
Howe, H.L., Chen, V.W., Hotes, J.L., Wu, X.C., Correa, C.N., Fulton, J.P. (Eds.) (2001) Cancer in North America, 1994-1998. Vol. 1. Incidence. Springfield, Ill.: North American Association of Central Cancer Registries.
Hultstrom, D. (Ed.) (2001) Standards for Cancer Registries. Volume II. Data Standards and Data Dictionary. Version 9.1, sixth edition. Springfield, Ill.: North American Association of Central Cancer Registries.
Jaffe, E.S., Harris, N.L., Stein, H., and Vardiman, J.W. (Eds.) (2001) WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press.
Kleihues, P., and Cavenee, W.K. (Eds.) (2000)Pathology and Genetics of Tumours of the Nervous System. 2nd Edition . Lyon: IARC Press.
Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993) The new WHO classification of brain tumours. Brain Pathol. 3,255 -268.[ISI][Medline]
Parkin, D.M., Shanmugaratnam, K., Sobin, L., Ferlay, J., and Whelan, S.L. (1998) Histological Groups for Comparative Studies. IARC Technical Report No. 31. Lyon: IARC Press. pp. 24-25, 40-41.
Percy, C.L., Van Holten, V., and Muir, C.S. (Eds.) (1990) International Classification for Diseases of Oncology. Second edition. Geneva: World Health Organization.
Schoenberg, B.S., Christine, B.W., and Whisnat, J.P.
(1976) The descriptive epidemiology of primary intracranial
neoplasms: The Connecticut experience. Am. J.
Epidemiol. 104,499
-510.
van der Sanden, G.A., Wesseling, P., Schouten, L.J., Teepen, H.L., and Coebergh, J. (1998). A uniform histological cluster scheme for ICD-O coded primary central nervous system tumors. Neuroepidemiology 17,233 -246.[CrossRef][ISI][Medline]
Walker, A.E., Robins, M., and Weinfeld,F. (1985)
Epidemiologyof brain tumors: The national survey of intracranial neoplasms.
Neurology 35,219
-226.
This article has been cited by other articles:
|
|
 |
|
  U. Lim, A. F. Subar, T. Mouw, P. Hartge, L. M. Morton, R. Stolzenberg-Solomon, D. Campbell, A. R. Hollenbeck, and A. Schatzkin Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1654 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wrensch, T. Rice, R. Miike, A. McMillan, K. R. Lamborn, K. Aldape, and M. D. Prados Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area Neuro-oncol, January 1, 2006; 8(1): 12 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. McCarthy, C. Kruchko, and Central Brain Tumor Registry of the United States Consensus Conference on Cancer Registration of Brain and Central Nervous System Tumors Neuro-oncol, April 1, 2005; 7(2): 196 - 201. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
